What are the differences between compounded and branded GLP-1s?

10 minute read

By: Hadley Mendelsohn|Last updated: March 20, 2026|Medically reviewed by: Amy Hayes
Woman standing at the beach wearing fitness clothing , looking away, holding a water bottle and yoga mat under her arm.

Summary

GLP-1 medications are used to address weight gain and metabolic changes during perimenopause and menopause, targeting appetite regulation, insulin resistance, and energy balance. Branded GLP-1s, such as Wegovy® and Ozempic®, are FDA-approved, standardized, and supported by extensive clinical data, while compounded GLP-1s are custom-prepared by licensed pharmacies for cases of drug shortages, insurance barriers, or specific dosing needs, though they are not individually FDA-approved. Both forms require medical supervision, can support weight loss, and may be combined with menopausal hormone therapy for a comprehensive approach to midlife weight management.

Why Weight Management Is Different in Perimenopause and Menopause

In midlife, your body can change even when your routines haven’t. For women, weight gain during this stage is largely thanks to perimenopause and menopause — which both bring real metabolic changes. 

Here’s what’s actually going on: As estrogen levels fluctuate and then decline, the body redistributes fat. More of it settles around the abdomen and also contributes to increasing visceral fat (the deeper fat that surrounds internal organs). 

This shift in body composition can happen even if the number on the scale doesn’t change dramatically, but it’s not just about aesthetics. Increased visceral fat is associated with higher risks of heart disease, insulin resistance, type 2 diabetes, and systemic inflammation. 

At the same time, muscle mass naturally decreases with age. Because muscle burns more energy than fat does, having less of it can lead to a lower resting metabolism. In other words, your body needs fewer calories to maintain itself. That’s why the strategies that worked in your 30s and 40s can suddenly feel ineffective.

While lifestyle changes are still foundational for weight management, some women may find that they benefit from extra medical support. Treatments like glucagon-like peptide-1 receptor agonists (GLP-1s for short) are one evidence-based option that can address the biology driving these changes. Let’s dig into how these meds work. 

What Are GLP-1 Medications and How Do They Work?

GLP-1 is a hormone your body naturally makes in your gut. Its job is to regulate blood sugar, appetite, and digestion. After you eat, GLP-1 signals the pancreas to release insulin, slows how quickly food leaves the stomach, and communicates with the brain to promote fullness.

GLP-1 receptor agonists (colloquially known as GLP-1s) are medications that mimic this hormone. In plainer terms, they boost the body’s satiety signaling. This means they minimize hunger and cravings, leaving people feeling satisfied with smaller portions. They also slow gastric emptying (the speed at which food moves from the stomach into the small intestine), helping stabilize blood sugar and further maintaining feelings of fullness.

By addressing insulin resistance, appetite signaling, and energy balance, GLP-1s can support weight loss and improve blood sugar control. And some research suggests that even low doses of GLP-1s can help with these issues during menopause. That said, they tend to be most effective when combined with good eating habits, strength training, and sleep support. 

GLP-1s are also available in both branded and compounded forms, so we’ll help break down the differences. and how they may come up for women navigating midlife. 

Compounded vs Branded GLP-1s: What’s the Difference?

Both branded and compounded GLP-1 medications require a prescription, ongoing medical supervision, and have similar active ingredients, but the way they’re manufactured, regulated, and distributed can differ.

Here’s a closer look: 

Branded GLP-1s

Branded GLP-1 medications are mass-produced by pharmaceutical manufacturers and reviewed through the FDA approval process for specific indications, doses, and formulations. 

Examples include:

  • Wegovy® (semaglutide)

  • Ozempic® (semaglutide)

  • Saxenda® (liraglutide

  • Victoza® (liraglutide) 

  • Zepbound® (tirzepatide)

  • Mounjaro® (tirzepatide)

These medications are standardized, meaning every pen or vial or pill contains the same FDA-approved formulation. They’ve been studied extensively in large clinical trials for safety, efficacy, and side effects.

Compounded GLP-1s

Compounded GLP-1s can expand access to treatment under several different circumstances, including when there’s a drug shortage, if a dosage is needed that isn’t commercially available, or if you have an allergy to one of the ingredients. 

Compounded medications can also be a great choice when branded versions have insurance barriers or cost limitations, which research shows are two big barriers

However, compounded medications aren’t individually FDA-approved in the same way branded drugs are. Instead, they’re manufactured by pharmacies that operate under federal and state regulatory standards, and can vary depending on the source. 

Alloy partners with FDA-regulated compounding pharmacies to prioritize safety, quality control, and appropriate dosing — so women have access to evidence-based care with medical guidance.

Benefits and What to Expect with Branded GLP-1s for Menopausal Weight Care

Branded GLP-1 medications come with something many women value: extensive data.

Medications like Wegovy® and Ozempic® have gone through the FDA approval process, which requires large clinical trials evaluating safety, dosing, and effectiveness. These studies have shown significant weight loss and improvements in blood sugar control and cardiovascular risk factors. For women navigating rising insulin resistance and visceral fat, this evidence matters.

Wegovy

Wegovy®

Starting at $199 $499

Another advantage is standardization. Branded medications are manufactured at scale with consistent dosing and delivery devices, like prefilled pens. In some cases, insurance coverage can also offset part of the cost (though this is more common when the meds are prescribed for diabetes). 

A key limitation? Access isn’t always straightforward or affordable. Out-of-pocket costs can be high, especially since many insurance plans don’t cover weight-related treatments. Coverage criteria can also be restrictive, requiring specific BMI thresholds or documented comorbidities, like sleep apnea and hypertension. 

For many women, branded GLP-1s offer a well-studied, standardized option. The question often isn’t whether they work - it’s whether they’re accessible.

Benefits and What to Expect with Compounded GLP-1s for Menopausal Weight Care

Compounded GLP-1s can be a more affordable and convenient option, especially if brand name versions aren’t widely available or covered by insurance. In other words, when cost or supply becomes a barrier, compounding can help bridge the gap.

So, what is the key difference? Compounded medications are custom-prepared by licensed pharmacies based on a clinician’s prescription. They require the same medical evaluation, dosing oversight, and follow-up as branded GLP-1s. But unlike the brand name versions, they aren’t individually FDA-approved. Instead, they’re prepared by pharmacies that must meet federal and state regulatory standards.

When sourced from reputable, FDA-regulated compounding pharmacies that follow strict quality and safety protocols, the results should align with what we know about how the active ingredient works. So the mechanism of action doesn’t change simply because the medication is compounded.

That said, compounded GLP-1s don’t have the same large-scale, brand-specific clinical trial data as commercially manufactured versions. Insurance coverage is also a key difference. In many cases, compounded medications are paid for out of pocket.

For women navigating midlife weight changes, the goal isn’t just access, but access done responsibly. So, it may ease your mind to know that, when accessed through Alloy, compounded GLP-1 medications are sourced from FDA-regulated pharmacies with rigorous quality standards and clinical oversight. 

Safety, Side Effects, and Regulatory Considerations

GLP-1 medications are generally considered safe when prescribed appropriately and monitored by a healthcare provider.

The most common side effects are gastrointestinal, including:

  • Nausea

  • Bloating

  • Constipation

  • Diarrhea

  • Vomiting

These tend to go away after the first few weeks of treatment or during dose increases when your digestive system adapts to the medication. To mitigate these, many healthcare providers work with patients on a dose titration schedule. This just means they slowly work up to a higher dose as the body adjusts. For most women, these symptoms are temporary. 

Some people also report redness or irritation around the injection site. 

In terms of regulation, branded GLP-1 medications are FDA-approved and manufactured at scale under federal oversight. Compounded GLP-1s aren’t individually FDA-approved, but they are prepared by licensed compounding pharmacies that operate under federal and state regulations. 

At Alloy, our compounded medications are sourced from FDA-regulated compounding pharmacies with strict quality standards.

More serious but less common risks can include:

  • Gallbladder disease

  • Pancreatitis

  • Worsening of diabetic retinopathy in patients with diabetes

  • Thyroid C-cell tumors observed in animal studies

Certain conditions, medications, or risk factors may influence whether a healthcare provider thinks GLP-1s are appropriate for you, so women should review their full medical history with a qualified provider before starting therapy. 

Cost, Accessibility, and Personalization: What Matters Most for Midlife Women

For many, the decision ultimately comes down to access and cost, which is where insurance comes into play. 

Insurance coverage for weight management with GLP-1s is inconsistent. Some plans require prior authorization, specific BMI thresholds, or documented health conditions. And even with coverage, copays can be high. 

Compounded GLP-1s aren’t usually covered by insurance either, but they’re often more affordable out of pocket. So, for those running into insurance roadblocks and/or high retail pricing, they can make treatment possible rather than theoretical.

Beyond cost, the care surrounding the prescription is also an important factor. GLP-1 treatment works best with ongoing lifestyle guidance based on your needs, as well as support throughout any side effects or weight loss plateaus you might experience. Getting personalized care is key to both comfort, safety, and long-term success.

Alloy’s Weight Care program includes personalized treatment plans, ongoing clinician oversight, 24/7 messaging, and monthly check-ins. The idea is simple: You’re not figuring this out alone, and there’s really no one “right” choice for everyone. What makes sense depends on what you can afford, what your insurance will cover, what’s actually available, and what your health history looks like. The goal is care that’s realistic, consistent, and built around your life.

Combining GLP-1s with Menopausal Hormone Therapy (MHT): A Synergistic Approach

Menopause weight loss is about addressing the metabolic shifts due to changing hormones. That’s where menopausal hormone therapy, or MHT, comes in. 

MHT works by replacing the estrogen that declines during perimenopause and menopause. In doing so, it can help address symptoms from hot flashes to sleep issues and mood changes. And when those symptoms improve, consistency with nutrition, movement, and strength training often does too. 

Estrogen therapy also plays a role in body fat distribution. It can help limit the increased abdominal and visceral fat that commonly occurs in midlife. While MHT isn’t a straightforward weight loss medication, it may support your general health and metabolism (as well as other menopause symptoms). 

GLP-1 medications, on the other hand, directly target appetite regulation, insulin response, and energy balance. When used together, MHT and GLP-1 therapy may complement each other. Early research and growing examples suggest that addressing both hormonal decline with MHT and metabolic changes with GLP-1 therapy could result in greater weight loss and metabolic improvements compared to either approach alone.  This is exciting news!

At Alloy, MHT and GLP-1 medications may both be prescribed when appropriate. The aim isn’t weight loss alone, but supporting the hormonal and metabolic shifts happening during menopause.

How to Choose: Questions to Ask Your Provider

Choosing a GLP-1 medication isn’t just about the drug itself. It’s also about whether the plan fits your health, your budget, and your life. If you’re not sure how to approach the conversation with your healthcare provider, start with your medical history. 

Be sure to share the full picture, including menopause symptoms, cardiovascular risk factors, family history, and any medications and supplements you’re currently taking. Hormones, blood sugar, thyroid health, and digestive history can all come into play. 

You should also feel free to ask them directly about the differences between branded and compounded options. Ask questions like, What are the pros and cons in my specific case? 

You could also ask other practical questions, like:

  • How much will treatment cost me monthly?

  • Will insurance cover it?

  • What happens if there’s a shortage of the medication you prescribe?

  • How will my dosage be adjusted over time?

This conversation is also a good time to go over side effects and understand how you can manage them if they come up. Ask things like:

  • What symptoms are expected early on? 

  • When should I call if I have these symptoms?

  • What will follow-up care look like?

A good provider should be able to walk you through all of this.

GLP-1s as Part of a Menopause Weight Care Strategy

GLP-1 medications can support meaningful weight loss in midlife. But they work best as part of a broader strategy.

Menopause shifts a lot at once. Hormones change. Sleep gets disrupted. Stress hits differently. Muscle mass drops. If you only address appetite, you may lose weight, but it can be harder to maintain.

Pairing GLP-1 therapy with strength training, adequate protein, better sleep, and, when appropriate, menopausal hormone therapy tends to make the process steadier. You’re working with biology instead of chasing it.

If you want more structure around that process, Alloy’s Weight Care program offers clinician support, regular check-ins, and direct messaging access.

The idea is regular care, not a one-time prescription, because midlife weight care is nuanced. The right approach depends on your symptoms, your history, and your goals. A clinical assessment can help you figure out whether GLP-1 therapy makes sense on its own or alongside other treatments.

“GLP-1 medications have become an important tool in addressing the metabolic changes that often accompany menopause, but it’s important for patients to understand the difference between FDA-approved, branded therapies and compounded versions.  When used appropriately, these medications can support meaningful weight loss and improvements in metabolic health, which are closely tied to long-term cardiovascular health and longevity.  Most importantly, they work best not as a standalone solution, but as part of a comprehensive plan that includes nutrition, physical activity, sleep, and stress management to truly optimize health and wellness during this stage of life.”


Frequently Asked Questions

Why does weight gain during menopause feel different than at other ages?

Weight gain during this stage is driven by a significant decline in estrogen, which causes the body to redistribute fat specifically toward the abdomen and internal organs as visceral fat. At the same time, a natural decrease in muscle mass lowers the resting metabolism, meaning the body requires fewer calories to maintain itself than it did in previous decades. These biological shifts, rather than just lifestyle habits, are why traditional weight management strategies often become less effective during the menopause transition.

How do GLP-1 medications specifically address the biological changes of menopause?

GLP-1 medications mimic a natural gut hormone to regulate appetite and blood sugar by signaling the brain to promote fullness and slowing the speed at which food leaves the stomach. By boosting satiety and addressing insulin resistance, these medications help counteract the metabolic shifts and increased cravings often triggered by hormonal fluctuations. When used alongside menopausal hormone therapy, they can provide a synergistic approach that addresses both the hormonal decline and the resulting metabolic challenges.

What is the primary difference between branded and compounded GLP-1 medications?

Branded GLP-1s are mass-produced, standardized medications that have undergone individual FDA approval through large-scale clinical trials for specific uses. Compounded GLP-1s are custom-prepared by licensed pharmacies and offer an alternative when there are drug shortages, insurance barriers, or a need for personalized dosages, though they are not individually FDA-approved. Both options require a prescription and medical supervision, and when sourced from regulated pharmacies, they use the same active ingredients to target the body's hunger and insulin pathways.

Related Content

  1. https://www.myalloy.com/

  2. https://www.myalloy.com/blog/how-do-glp-1s-work

  3. https://www.myalloy.com/blog/why-glp-1s-and-mht-are-a-beneficial-combination

  4. https://www.myalloy.com/blog/midlife-weight-gain-why-is-it-so-hard-to-lose

  5. https://www.myalloy.com/blog/what-is-compounded-liraglutide

  6. https://www.myalloy.com/weight

  7. https://www.myalloy.com/blog/are-glp-1-medications-safe-and-what-about-side-effects

  8. https://myalloy.zendesk.com/hc/en-us/articles/39471023349523-Can-I-take-GLP-1-medication-with-Menopausal-Hormone-Therapy-MHT

  9. https://www.youtube.com/watch?v=PVFjrKs1Kog

  10. https://www.youtube.com/watch?v=yy2nssEtL8k

Citations

  1. Joana Nicolau, Jorge Blanco-Anesto, Aina Bonet, Juan José Félix-Jaume, Apolonia Gil-Palmer. Effectiveness of Low Doses of Semaglutide on Weight Loss and Body Composition Among Women in Their Menopause. Metab Syndr Relat Disord 2025;23(1):70-76. PMID:39761057.

    View source
  2. Santiago Palacios, Peter Chedraui, Rafael Sanchez-Borrego, Pluvio Coronado, Tommaso Simoncini, Katrin Schauding, et al.. Management of obesity in menopause. Climacteric 2024;27(4):357-363. PMID:39016333.

    View source
  3. Satish Jankie, Lexley Maureen Pinto Pereira. Targeting insulin resistance with selected antidiabetic agents prevents menopausal associated central obesity, dysglycemia, and cardiometabolic risk. Post Reprod Health 2021;27(1):45-48. PMID:33356861.

    View source
  4. Sunil V Badve, Anika Bilal, Matthew M Y Lee, Naveed Sattar, Hertzel C Gerstein, Christian T Ruff, et al.. Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol 2025;13(1):15-28. PMID:39608381.

    View source
  5. Brendon L Neuen, Robert A Fletcher, Lauren Heath, Adam Perkovic, Muthiah Vaduganathan, Sunil V Badve, et al.. Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Circulation 2024;150(22):1781-1790. PMID:39210781.

    View source
  6. Maneeha Naveed, Cecilie Perez, Ehtasham Ahmad, Laura Russell, Zoe Lees, Catriona Maybury. GLP-1 medication and weight loss: Barriers and motivators among 1659 participants managed in a virtual setting. Diabetes Obes Metab 2025;27(7):3780-3788. PMID:40259493.

    View source
  7. Yao-Yi Kuo, Hao-Yun Chang, Yu-Chen Huang, Che-Wei Liu. Effect of Whey Protein Supplementation in Postmenopausal Women: A Systematic Review and Meta-Analysis. Nutrients 2022;14(19). PMID:36235862.

    View source
  8. Jorge F A Model, Rafaella S Normann, Éverton L Vogt, Maiza Von Dentz, Marjoriane de Amaral, Rui Xu, et al.. Interactions between glucagon like peptide 1 (GLP-1) and estrogens regulates lipid metabolism. Biochem Pharmacol 2024;230(Pt 3):116623. PMID:39542180.

    View source

Share this post

Subscribe

Go ahead, you deserve to

feel fantastic

Stay connected

Follow us